Download this slideset from an expert roundtable discussion covering the latest insights on PARP inhibitors for frontline maintenance treatment in patients with ovarian cancer.
This educational activity is intended for clinicians practicing medicine outside of the United States.
Experts provide their thoughts on key data in breast and gynecologic cancers from the 2022 ASCO Annual Meeting, from Clinical Care Options (CCO)
Commentary on novel agents for platinum-resistant ovarian cancer, from Clinical Care Options (CCO)
Interactive online tool with expert management recommendations for selecting therapy for women with ovarian cancer, from Clinical Care Options (CCO)
Gain important nursing insights on the management of patients with gynecologic cancers in this program from Clinical Care Options (CCO)